The purpose of this trial is to assess the bioequivalence (BE) of new 600 milligram (mg)
Cisticid tablet (Test) versus 600 mg Biltricide tablets (Reference) at a dose of 1200 mg in
healthy male participants. Praziquantel (PZQ) is the active ingredient for Cisticid and
Biltricide tablets.